Background
Objective
Methods
Results
Conclusion
Keywords
- ▪A machine learning model fed raw photoplethysmography (PPG) waveform data seems to more accurately discriminate atrial fibrillation from sinus rhythm compared to conventional heart rate variability measurements.
- ▪A machine learning model fed raw PPG waveform data seems to more accurately discriminate atrial fibrillation from sinus rhythm compared to a machine learning model using heart rate information alone.
- ▪Restriction to sedentary individuals undergoing cardioversion in this study may not apply to ambulatory free-living individuals in the community.
Introduction
Methods
Study design
Study sample
Data collection procedure
Statistical analysis
Model 1: Conventional approach
Model 2: LSTM neural net
Model 3: DNN
Results
Participant characteristics
Baseline characteristics | Train (n = 40) | Test (n = 11) | P value |
---|---|---|---|
Mean age (y) | 62.8 ± 11.0 | 65.6 ± 14.4 | .48 |
Male | 30 (75%) | 10 (91%) | .26 |
White | 36 (90%) | 9 (82%) | .46 |
Body mass index (kg/cm2) | 30.2 ± 6.2 | 30.0 ± 6.3 | .91 |
Medical characteristics | |||
Hypertension | 20 (50%) | 8 (73%) | .18 |
Diabetes mellitus | 10 (25%) | 1 (9%) | .26 |
Coronary artery disease | 4 (10%) | 0 (0%) | .27 |
Congestive heart failure | 4 (10%) | 1 (9%) | .91 |
Obstructive sleep apnea | 17 (43%) | 4 (36%) | .71 |
Myocardial infarction | 3 (8%) | 1 (9%) | .86 |
Cardiomyopathy | 4 (10%) | 1 (9%) | .93 |
Valvular heart disease | 2 (5%) | 0 (0%) | .45 |
Chronic obstructive pulmonary disease | 1 (3%) | 0 (0%) | .60 |
Previous cardioversion | 19 (48%) | 6 (55%) | .68 |
Stroke | 2 (5%) | 1 (9%) | .61 |
Treatment characteristics | |||
Beta-blocker | 22 (55%) | 9 (82%) | .11 |
Antiarrhythmic drug | 25 (63%) | 4 (36%) | .12 |
Anticoagulant drug | 38 (95%) | 11 (100%) | .45 |
Procedural characteristics | |||
No. of shocks | 1.3 ± 0.9 | 1.1 ±0.3 | .22 |
Successful cardioversion | 34 ± 0.4 | 9 ± 0.4 | .80 |
Joules delivered | 306.5 ± 312 | 242.7 ± 117 | .30 |


Model selection
Algorithm type | AUC | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) |
---|---|---|---|---|---|
Conventional heart rate variability (model 1) | 0.717 | 74.1 | 58.4 | 80.8 | 48.8 |
Machine learning fed heart rate only data (model 2) | 0.954 | 81.0 | 92.1 | 96.0 | 67.1 |
Machine learning fed raw waveform data (model 3) | 0.983 | 98.5 | 88.0 | 95.1 | 96.2 |


Discussion
Study limitations
Conclusion
Appendix. Supplementary data

- Supplementary Table 1
- Supplementary Table 2
References
- Atrial fibrillation and the risk of myocardial infarction.JAMA Intern Med. 2014; 174: 107-114
- Atrial fibrillation begets myocardial infarction.JAMA Intern Med. 2014; 174: 5-7
- Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.Circulation. 2013; 5: 569-574
- Atrial fibrillation and dementia.Trends Cardiovasc Med. 2015; 25: 44-51
- Heart disease and stroke statistics—2019 update: a report from the American Heart Association.Circulation. 2019; 139: e56-e528
- Cryptogenic stroke and underlying atrial fibrillation.N Engl J Med. 2014; 370: 2478-2486
- A novel application for the detection of an irregular pulse using an iPhone 4S in patients with atrial fibrillation.Heart Rhythm. 2013; 10: 315-319
- Deep learning.Nature. 2015; 521: 436-444
- Passive detection of atrial fibrillation using a commercially available smartwatch.JAMA Cardiol. 2018; 3: 409-416
- An efficient algorithm for automatic peak detection in noisy periodic and quasi-periodic signals.Algorithms. 2012; 5: 588-603
- Long short-term memory.Neural Comput. 1997; 9: 1735-1780
- End-to-end deep learning from raw sensor data: atrial fibrillation detection using wearables.ArXiv. 2018; (: arXiv:1807.10707)
- Prevention of atrial fibrillation: report from a National Heart, Lung, and Blood Institute workshop.Circulation. 2009; 119: 606-618
- Diagnostic accuracy of a novel mobile phone application for the detection and monitoring of atrial fibrillation.Am J Cardiol. 2018; 121: 1187-1191
- Diagnostic performance of a smartphone-based photoplethysmographic application for atrial fibrillation screening in a primary care setting.J Am Heart Assoc. 2016; 5 (e003428)
- Monitoring and detecting atrial fibrillation using wearable technology.Proc Annu Int Conf IEEE Eng Med Biol Soc EMBS. 2016; : 3394-3397
- Smartwatches in the fight against atrial fibrillation: the little watch that could.J Am Coll Cardiol. 2018; 71: 2389-2391
- Smartphone ownership and internet usage continues to climb in emerging economics. Pew Research Center. February 22, 2016.(Available from:)
Article info
Footnotes
Dr Tison received support from the National Institutes of Health (NHLBI K23HL135274). Dr Aschbacher has received research funding from Jawbone Health. The research was supported by Jawbone Health. Jawbone Health had no role in data collection or the overall experimental design of the study. Jawbone Health developed the neural networks used for data analyses. Prior to the design or origin of this study, Dr Aschbacher was previously employed by Jawbone. Drs Li, Kerem, Crawford, and Benaron, Ms Liu, and Ms Eaton are employees of Jawbone Health. Dr Tison holds equity in Cardiogram. Dr Marcus has received research funding from Jawbone Health, Eight, Baylis Medical, and Medtronic; and is a consultant for and holds equity in InCarda. Various components of these data, which have been included here in a single manuscript, were presented at the KDD Deep Learning Day, London, United Kingdom, August 2018; and the American Heart Association Scientific Sessions, Chicago, Illinois, November 2018. The corresponding author had final responsibility for the decision to submit for publication.
Identification
Copyright
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy